Is InflaRx N.V. (IFRX)’s Fuel Running Low? The Stock Reaches All Time High Today

April 22, 2018 - By Linda Rogers

The stock of InflaRx N.V. (NASDAQ:IFRX) reached all time high today, Apr, 22 and still has $40.32 target or 4.00 % above today’s $38.77 share price. This indicates more upside for the $907.64M company. This technical setup was reported by Barchart.com. If the $40.32 PT is reached, the company will be worth $36.31 million more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock increased 4.39% or $1.63 during the last trading session, reaching $38.77. About 50,021 shares traded. InflaRx N.V. (NASDAQ:IFRX) has 0.00% since April 22, 2017 and is . It has underperformed by 11.55% the S&P500.

InflaRx GmbH, a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology in the United States. The company has market cap of $907.64 million. The Company’s C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. It currently has negative earnings. The firm is involved developing IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and other chronic/autoimmune diseases, as well as IFX-2 for the treatment of chronic inflammation and autoimmune diseases.

InflaRx N.V. (NASDAQ:IFRX) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.